(R)-2-(4-Bromophenyl)propanoic acid, 98%, 5g

Methyl 2-(4-chloro-2-nitrophenyl)acetate, 97%, 250mg

1-Piperidine-4-ylethanol, 95.0%, 100mg

5-(Phenoxymethyl)-1,3,4-oxadiazol-2-amine, 95.0%, 2.5g

4,6-Bis((S)-4-benzyl-4,5-dihydrooxazol-2-yl)dibenzo[b,d]furan, 97%, 250mg

2-Methyl-2-adamantanol, min. 98%, for synthesis, 1 g, glass packaging

[(2-phenyl-1,3-oxazol-4-yl)methyl]amine hydrochloride, 95.0%, 1g

5'-Bromo-[2,2'-bithiophene]-5-carbonitrile>98.0%(GC)200mg

(R)-1-Boc-3-Hydroxymethylpyrrolidine, 95.0%, 25g

1-(2-Fluorobenzyl)cyclobutanecarboxylic acid, 1g

p-Nitrophenyl Formate, 98%, 1g

4-Methylpiperidin-4-ol, 95.0%, 1g

C-(1-Benzyl-pyrrolidin-3-yl)-methylamine, 95.0%, 5g